Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. - Wikidata - wikimedia - TriplyDB

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

http://www.wikidata.org/entity/Q45199316

about

Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit.Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitis Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review Dalbavancin: a novel antimicrobial Antimicrobial resistance: the example of Staphylococcus aureus Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections Three-dimensional structure of MecI. Molecular basis for transcriptional regulation of staphylococcal methicillin resistance Structural and mutational analyses of Drp35 from Staphylococcus aureus: a possible mechanism for its lactonase activity Structural Basis for Multimeric Heme Complexation through a Specific Protein-Heme Interaction: THE CASE OF THE THIRD NEAT DOMAIN OF IsdH FROM STAPHYLOCOCCUS AUREUS Crystal Structures of the Glycopeptide Sulfotransferase Teg12 in a Complex with the Teicoplanin Aglycone Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model Response of methicillin-resistant Staphylococcus aureus to amicoumacin A Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach Detection of Staphylococcus aureus delta-toxin production by whole-cell MALDI-TOF mass spectrometry Cartography of methicillin-resistant S. aureus transcripts: detection, orientation and temporal expression during growth phase and stress conditions Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.Coagulase-negative staphylococci.Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Methicillin-resistant Staphylococcus aureus: a 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia.Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options."The post-antibiotic apocalypse" and the "war on superbugs": catastrophe discourse in microbiology, its rhetorical form and political function.In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.

P2860

Q24532922-C4928789-0FC4-448F-A010-E7E637CEC490 Q24550603-B229363D-6D92-4880-AF98-AAA1345F750F Q24614464-77F1762A-68B4-4E57-BB02-7478EA4D9C85 Q24646621-522260B2-F488-4BB8-9AD3-49BFC464356E Q24646677-590A75FE-1DE8-46CE-BAF9-B436CA04017C Q24647429-7D22E0EA-7827-4A58-BCC2-D99C42878B9D Q24674841-626E52AE-E082-4E10-AFC4-630BFF9CF81B Q24676363-1CA672F9-1B3F-4EE5-9BFA-75D6852F28F3 Q24810927-52503504-4FAF-426A-BDEB-3F0FDE2F9CF0 Q26796560-301728FD-ED46-4B08-AD8F-A02C792C4FC4 Q27011138-4CB1B00F-83CA-4231-9109-5583A14CE088 Q27641736-BA533461-17F3-457D-B452-033BFB20F948 Q27643299-354A0B7F-8C7E-41FD-AAE9-EAFEF87C24BB Q27651383-CEA99C9A-169E-4ED8-AB5C-5FA5321773A3 Q27660400-296679C2-1622-4667-9EB7-04EF26BA3E6E Q28078930-62CF60CB-3D4D-49F0-93F9-55D8680BDCFD Q28196747-86CC9FC9-DF6E-4C1A-986D-25834D44FA9B Q28344792-3EABE8C5-884E-4E23-83AE-B175100B371E Q28362193-0DBE5BAD-D122-45C8-9AF4-11E1CF40EC44 Q28477900-B2AFFA8D-73CD-4077-A5A5-5BCED1793F2C Q28481497-92D8EB16-5356-4C62-9D30-4359302E3DEF Q28482069-E0C3B7EF-6458-4618-9D02-DA866B706DEE Q28601378-61B07B2C-E1D5-431B-A545-990E7391CF5B Q28727420-3155424A-DFF0-4DCD-8A2E-050CF5548BC1 Q28752025-8DB5C5E7-7660-4768-91C9-FBB4AE5C55EB Q30370676-42D7DBF9-5394-4E7D-B5B7-5B461EC9A176 Q30401758-D0E6B9C8-9648-41E5-BCBD-0C4483938737 Q30872027-5C3E5F41-A76C-4FF8-A423-2F907D4E34A6 Q31144203-81DFD45C-704C-438D-88A6-A6AF9ABEE8AD Q31704853-6A54C190-244D-4347-8606-8A6396C240C8 Q32092345-309F0B09-684F-41A2-B8AD-B99C4A38AD3C Q33220466-9D46AB01-5D9B-4ED0-B689-35FEFB818820 Q33264418-C5FFB419-DB15-48F5-8484-1509A5A2E5C2 Q33290348-68834A50-0DF4-42CB-9BCC-1B7E44870DEA Q33382969-678453F9-B35F-4D74-9D0E-38445ED9F5B5 Q33460707-8EE6640D-471A-4E7D-B2A5-9457A90CB949 Q33520285-A8ABE1DC-15A3-4EF6-8F17-4A25C5D2855F Q33559139-FA869020-467A-4E62-9ACD-6B1853A7B839 Q33593883-0C46C315-FD9C-43DB-89B2-A25B83BC316E Q33594576-E640C4CB-4E21-4895-911E-BE5ACF828B74

P2860

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

http://www.wikidata.org/entity/Q45199316

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh-hant

name

Dissemination in Japanese hosp ...... ously resistant to vancomycin.

@en

Dissemination in Japanese hosp ...... ously resistant to vancomycin.

@nl

type

label

Dissemination in Japanese hosp ...... ously resistant to vancomycin.

@en

Dissemination in Japanese hosp ...... ously resistant to vancomycin.

@nl

prefLabel

Dissemination in Japanese hosp ...... ously resistant to vancomycin.

@en

Dissemination in Japanese hosp ...... ously resistant to vancomycin.

@nl

P1433

Q45199316-6709E7F4-AB8A-47BC-8163-A9661B0B4886

P1476

Q45199316-E6038DA7-0506-449F-8196-3DAFFA9B4358

P2093

Q45199316-1048C3EE-03A0-443D-B5E7-62A8C8173BA6

Q45199316-2CCF2D9B-04B2-439B-B5DF-8C34F99A42B2

Q45199316-78985BF2-9784-4450-8FC4-E8DCCE7E35B5

Q45199316-BBF68CAC-B9C2-4B85-96B2-7BC4FF0902AC

Q45199316-BC5A5F11-87A5-4293-AFE3-68E278B16C39

Q45199316-E2A0B793-1051-40A4-9517-E6E484AD19C9

Q45199316-F38063CC-D7C0-4BD5-8132-B53EC00F8B4D

Q45199316-FAE792C9-6EA2-4972-9B24-697CEF429390

P304

Q45199316-5FA4EBF1-181B-4854-9209-0647F90A7B7F

P31

Q45199316-2882B8E0-3F8E-4B8D-884D-79CD4E7924BC

P356

Q45199316-4E70FB40-3BCE-4C17-84E4-61D9552B577C

P407

Q45199316-140379C4-4ACD-483C-A674-880791C037B7

P433

Q45199316-CD402A1C-393F-4130-B0C9-5362919B85DE

P478

Q45199316-2BD660F2-8BDE-45AB-BD44-08C223F53EB9

P577

Q45199316-BFCB4ABF-F7D3-4BC6-8755-2A8D36C5CF87

P698

Q45199316-717E71BA-04A5-4780-A4E0-C05887D2DBFB

P356

S0140-6736(97)07324-8

P1433

P1476

Dissemination in Japanese hosp ...... ously resistant to vancomycin.

@en

P2093

H Hanaki

http://www.w3.org/2001/XMLSchema#string

I Kobayashi

http://www.w3.org/2001/XMLSchema#string

K Hiramatsu

http://www.w3.org/2001/XMLSchema#string

N Aritaka

http://www.w3.org/2001/XMLSchema#string

S Hori

http://www.w3.org/2001/XMLSchema#string

S Kawasaki

http://www.w3.org/2001/XMLSchema#string

Y Fukuchi

http://www.w3.org/2001/XMLSchema#string

Y Hosoda

http://www.w3.org/2001/XMLSchema#string

P304

1670-1673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(97)07324-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

9092

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9400512

http://www.w3.org/2001/XMLSchema#string